Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Peringkat dalam Saham #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Harga Saham
$419.17
Kapitalisasi Pasar
$333.66B
Perubahan (1 hari)
0.50%
Perubahan (1 tahun)
14.13%
Negara
CH
Perdagangan Roche Holding AG (ROG)

Kategori

Laba untuk Roche Holding AG (ROG)
Laba pada Dec 2025 TTM: $21.39B
Menurut laporan keuangan terbaru dari Roche Holding AG, laba saat ini perusahaan adalah $21.39B. Pada tahun 2024, perusahaan memperoleh laba sebesar $13.06B, penurunan dibandingkan dengan laba tahun 2023 sebesar $16.74B. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Roche Holding AG dari 2000 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara